VYNE Therapeutics Inc. (VYNE) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -4.08M | -3.76M | -7.1M | -10.8M | -11.46M | -9M | -8.51M | -8.48M | -7.98M | -5.14M | -5.15M | -9.57M | -5.48M | -3.88M | -7.13M | -8.22M | -9.04M | -10.02M | -17.54M | -16.26M |
| Operating CF Margin % | -4745.35% | -2895.38% | -4198.82% | -15656.52% | -5673.76% | -10713.1% | -7033.06% | -4283.84% | -8143.88% | -6759.21% | -4519.3% | -7091.85% | -5533.33% | -64583.33% | -4266.47% | -6527.78% | -5078.09% | -437.09% | -13188.72% | -5510.85% |
| Operating CF Growth % | 64.39% | 58.17% | 16.62% | -27.36% | -43.6% | -75.18% | -65.18% | 11.41% | -45.69% | -32.57% | 27.69% | -16.4% | 39.4% | 61.32% | 59.38% | 49.41% | 27.98% | 60.52% | 25.79% | 54.66% |
| Net Income | -3.58M | -4.84M | -7.28M | -5.75M | -8.61M | -12.02M | -12.16M | -9.41M | -6.25M | -6.19M | -6.07M | -10.04M | -5.61M | -9.95M | -9.26M | -8.48M | 4.67M | -11.57M | -14.28M | -10.69M |
| Depreciation & Amortization | -12K | 5K | 6K | 6K | 6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -155K | 171K | 12K | 44K | 26K | 28K | 28K |
| Stock-Based Compensation | 474K | 529K | 487K | 529K | 763K | 699K | 734K | 885K | 985K | 710K | 0 | 0 | 0 | 1.07M | 0 | 1.16M | 893K | 1.33M | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 93K | 0 | 0 |
| Other Non-Cash Items | 0 | -90K | -150K | -214K | -324K | -541K | -505K | -616K | -778K | -254K | 350K | 856K | 846K | 280K | 1.01M | 40K | -12.99M | 1.3M | -1.74M | -7.42M |
| Working Capital Changes | -958K | 629K | -159K | -5.37M | -3.29M | 2.87M | 3.42M | 655K | -1.94M | 595K | 569K | -392K | -712K | 4.88M | 950K | -964K | -1.65M | -1.2M | -1.55M | 1.82M |
| Change in Receivables | 202K | 2.27M | 1.63M | 1.07M | -768K | 688K | 2.54M | -2.83M | -1.29M | 482K | -16K | -129K | 68K | 2.36M | 877K | 231K | 7.98M | 2.45M | 996K | -798K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 97K | 779K | 209K | -187K |
| Change in Payables | -1.16M | -1.65M | -1.77M | -6.41M | -2.49M | 2.2M | 903K | 3.52M | -611K | 0 | 77K | 0 | 0 | 0 | 104K | 0 | 0 | -2.67M | -3.09M | 3.05M |
| Cash from Investing | 4.7M | 8.46M | 4.4M | 4.67M | 19.83M | 12.74M | -4.82M | 19.02M | -3.57M | -62.35M | 0 | 0 | 5M | -935K | -86K | 0 | 15.75M | 0 | 0 | 1.03M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | -117K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | 139.29% | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5M | -935K | -86K | 0 | 15.75M | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -62.35M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | -15K | -15K | -7K | -34K | -87K | -132K | -2K | -2K | -5K | 82.66M | -47K | -5K | -217K | 208K | -26K | -61K | 1.53M | -38K | -33.56M | -129K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -36.43M | 0 |
| Equity Issued (Net) | -15K | 0 | 0 | -34K | 0 | 0 | 0 | 0 | 0 | 82.67M | -47K | -5K | -217K | -1K | -26K | -86K | 1.56M | -29K | 2.87M | -129K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | -34K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -360K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | -15K | -7K | 0 | -87K | -132K | -2K | -2K | -5K | -2K | 0 | 0 | 0 | 209K | 0 | 25K | -25K | -9K | 0 | 0 |
| Net Change in Cash | 604K | 4.68M | -2.7M | -6.16M | 8.28M | 3.61M | -13.34M | 10.54M | -11.55M | 15.17M | -5.2M | -9.58M | -695K | -4.6M | -7.24M | -8.29M | 8.24M | -10.06M | -51.1M | -15.36M |
| Free Cash Flow | -4.08M | -3.76M | -7.1M | -10.8M | -11.46M | -9.12M | -8.51M | -8.48M | -7.98M | -5.14M | -5.15M | -9.57M | -5.48M | -3.88M | -7.13M | -8.22M | -9.04M | -10.02M | -17.54M | -16.26M |
| FCF Margin % | -4745.35% | -2895.38% | -4198.82% | -15656.52% | -5673.76% | -10852.38% | -7033.06% | -4283.84% | -8143.88% | -6759.21% | -4519.3% | -7091.85% | -5533.33% | -64583.33% | -4266.47% | -6527.78% | -5078.09% | -437.09% | -13188.72% | -5510.85% |
| FCF Growth % | 64.39% | 58.71% | 16.62% | -27.36% | -43.6% | -77.46% | -65.18% | 11.41% | -45.69% | -32.57% | 27.69% | -16.4% | 39.4% | 61.32% | 59.38% | 49.41% | 27.98% | 60.7% | 25.79% | 54.75% |
| FCF per Share | -0.10 | -0.09 | -0.17 | -0.25 | -0.27 | -0.21 | -0.20 | -0.20 | -0.19 | -0.17 | -1.57 | -2.93 | -1.68 | -1.30 | -2.21 | -2.56 | -2.94 | -3.37 | -6.07 | -5.69 |
| FCF Conversion (FCF/Net Income) | 1.14x | 0.78x | 0.97x | 1.88x | 1.33x | 0.75x | 0.70x | 0.90x | 1.28x | 0.83x | 0.78x | 0.95x | 0.97x | 0.39x | 0.75x | 0.97x | -1.94x | 0.87x | 0.82x | 0.82x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |